Regenerative medicine legislation in Japan for fast provision of cell therapy products-Reference-Cited by-同舟云学术

Regenerative medicine legislation in Japan for fast provision of cell therapy products

Published:2015-11-20 Issue:1 Volume:99 Page:26-29
ISSN:0009-9236
Container-title:Clinical Pharmacology & Therapeutics
language:en
Short-container-title:Clin. Pharmacol. Ther.

Author:

Fujita Y¹,Kawamoto A¹²

Affiliation:

1. Unit of Regenerative Medicine, Institute of Biomedical Research and Innovation; Foundation for Biomedical Research and Innovation; Chuo-ku Kobe Japan

2. Translational Research Informatics Center; Foundation for Biomedical Research and Innovation; Chuo-ku Kobe Japan

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Reference5 articles.

1. Induction of pluripotent stem cells from adult human fibroblasts by defined factors;Takahashi;Cell,2007

2. Isolation of putative progenitor endothelial cells for angiogenesis;Asahara;Science,1997

3. New governmental regulatory system for stem cell-based therapies in Japan;Hara;Ther. Innov. Regul. Sci.,2014

4. A new national framework for clinical trials and evaluation of innovative medical care technologies using living cells transplantation in Japan;Okada;J. Transplant. Technol. Res.,2014

5. Pharmaceuticals, Medical Devices, and Other Therapeutic Products Act [in Japanese] 2013 http://www.mhlw.go.jp/topics/bukyoku/soumu/houritu/dl/183-55.pdf

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Assessment of Surrogate End Point Trends in Clinical Trials to Approve Oncology Drugs From 2001 to 2020 in Japan;JAMA Network Open;2023-04-28

2. Impact and challenges of enactment for advanced regenerative medicine in South Korea;Frontiers in Bioengineering and Biotechnology;2022-10-12

3. Allogeneic Mesenchymal Stem Cell-Based Treatment Legislation in Latin America: The Need for Standardization in a Medical Tourism Context;Stem Cells and Development;2022-04-01

4. Regenerative Medicine in South Korea: Bridging the Gap Between Authorization and Reimbursement;Frontiers in Bioengineering and Biotechnology;2021-08-30

5. New developments in corneal endothelial cell replacement;Acta Ophthalmologica;2020-12-24